INTENSIVE STATIN THERAPY VERSUS UPFRONT COMBINATION THERAPY OF STATIN AND EZETIMIBE IN PATIENTS WITH ACUTE CORONARY SYNDROME: A PROPENSITY SCORE MATCHING ANALYSIS BASED ON THE PL‐ACS DATA

Within the group of the recognized Polish experts, based on the data from the PL-ACS Registry, for the first time in the world we confirmed that the upfront combination lipid-lowering therapy is superior to statin monotherapy for all-cause mortality in patients with ACS. These results suggest that in high-risk patients, such an approach, rather than a stepwise therapy approach, should be recommended.

https://www.ahajournals.org/doi/10.1161/JAHA.123.030414?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

Share:

Facebook
Twitter
LinkedIn

Related Posts